Research Grants
The leading funder of multiple myeloma research
As the leading funder of multiple myeloma research, the MMRF has supported more than 380 research grants at over 135 institutions worldwide. The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grant-making programs.
We remain committed to supporting researchers who have more than five years experience in blood cancer research as well as attracting younger scientists to enter the myeloma research field to build the next generation of scientific leaders.
Grant Opportunities:
The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award programs and from biotech companies with investigational agents for multiple myeloma. For traditional research grants, applications are accepted from non-profit institutions and universities in the United States and internationally. Program guidelines and applications are available approximately 6-8 weeks prior to the submission deadline.
The MMRF ImmunoOncology in Multiple Myeloma Innovations program RFA:
The Multiple Myeloma Research Foundation (MMRF) is pleased to announce a new Clinical and Translational research program to investigate novel, hypothesis-driven, ImmunoOncology (IO) strategies for Multiple Myeloma. Currently, the IO treatment landscape features a wide array of approved and investigational IO strategies, presenting a significant challenge of combining and sequencing these agents for the optimal clinical response in the appropriate patient populations.
The MMRF ImmunoOncology in Multiple Myeloma Innovations program RFA will support innovative, hypothesis-driven clinical trials that are paired with correlative studies designed to demonstrate mechanisms of action or resistance, biomarkers for patient selection, and identification of ancillary targets.
The MMRF encourages the submission of collaborative projects involving academic institutions and pharmaceutical industry partners.
The MMRF ImmunoOncology in Multiple Myeloma Innovations program Guidelines
2019 Myeloma Immune Translational Research Accelerator Program RFA:
The Multiple Myeloma Research Foundation (MMRF) is pleased to announce a new translational research program focused on advancing our understanding of patient immunity in myeloma disease biology. The overall goal of this award is to support cutting-edge immune translational research projects that explore clinically relevant questions on immune therapy and accelerate immune precision medicine for multiple myeloma patients.
The MMRF seeks proposals exploring clinically relevant translational research questions that will improve our understanding of cellular therapies in myeloma and accelerate the development of the next wave of such agents for our patients. The specific research areas of interest for this grant include, but are not limited to: mechanisms of response and resistance to ACTs, next generation cellular therapy, constructs and delivery systems, novel ACT targets, and novel cellular therapies biomarkers and diagnostics. Applications for the 2019 Myeloma Immune Translational Research Accelerator Program are due Friday, June 28, 2019.
2019 Myeloma Immune Translational Research Accelerator Program Guidelines
Research Fellow Awards:
For researchers who hold a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow or assistant professor levels who are beginning studies in the multiple myeloma field under the supervision of a research mentor or sponsor. Applicants may request up to $75,000 for one year. Application deadline: June 24, 2019 at 5PM EST
2019 Research Fellows applicant guidelines
MMRF Research Fellow Award Program Fosters Next Generation of Myeloma Researchers
The Multiple Myeloma Research Foundation has named the recipients of the 2018 MMRF Research Fellow Award Program. This program aims to prepare and support the next generation of young investigators who are at the forefront of research into myeloma disease biology, patient response to treatment and drug resistance and the advancement of precision medicine in the field of myeloma.
The 2018 Research Fellow Award Winners are:
Luca Busino, Assistant Professor, Department of Cancer Biology, Assistant Investigator, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania
- Exploiting the KLHL6 pathway for the therapy of myeloma
Yanyan Gu, Associate Scientist, Department of Hematology & Medical Oncology, Emory University
- Regulation of MHC class II expression by 14-3-3ζ (zeta) in human MM cells
Andrea Reboldi, PhD, Assistant Professor Department of Pathology, University of Massachusetts Medical School
- Project Title: Cholesterol metabolism reprogramming during multiple myeloma pathogenesis
Search Research Grants
| Year Awarded |
Type |
Investigator |
A Combination Strategy Targeting The Bcl-2 Family In Multiple Myeloma
Virginia Commonwealth University
Validation of Novel Combinations
Investigator: Steven Grant
Amount: $100,000
Year awarded: 2007
Adoptive Immunotherapy With Donor Myeloma-specific T Cells
University of Texas
Senior Research Award
Investigator: Larry Kwak
Amount: $100,000
Year awarded: 2006
An Integrated Study Of Proteostasis Against Multiple Myeloma
Fondazione Centro San Raffaele del Monte Tabor
Senior Research Award
Investigator: Simone Cenci
Amount: $200,000
Year awarded: 2010
A Novel Aurora Kinase Inhibitor, AT9283, And Lenalidomide In MM
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Loredana Santo
Amount: $75,000
Year awarded: 2010
Anti-Pleiotrophin-Mediated Therapy For The Treament Of Multple Myeloma
The Institute for Myeloma and Bone Cancer Research
Validation of Novel Combinations
Investigator: James Berenson
Amount: $100,000
Year awarded: 2006
Anti-b2M Monoclonal Antibodies As Therapeutic Agent For Myeloma
University of Texas
Senior Research Award
Investigator: Qing Yi
Amount: $200,000
Year awarded: 2008
A Proteomic Approach To Discover Novel Monoclonal Antibody Targets
The Chancellor, Masters, and Scholars of the University of Cambridge
Senior Research Award
Investigator: Michael Chapman
Amount: $200,000
Year awarded: 2014
A Systems Approach For Identifying Possible Drug Combinations In Myeloma
National Cancer Institute
Research Fellow Award
Investigator: John Simmons
Amount: $75,000
Year awarded: 2014
A Transgenic Model Of Multiple Myeloma
University of Pittsburgh
Animal Model Development Award
Investigator: PREET CHAUDHARY
Amount: $200,000
Year awarded: 2007
Beta 1 Integrin Inhibitory Peptides: Novel Agents For The Treatment Of MM
Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Lori Hazlehurst
Amount: $200
Year awarded: 2008
Biomarker Discovery And Validation In Multiple Myeloma Cells Using Multiple Proteomic Platforms.2007
Indiana University Indianapolis
Proteomics Award
Investigator: Mu Wang
Amount: $750,000
Year awarded: 2007
Cell Cycle Based Combination Therapy For Multiple Myeloma
Cornell University
Senior Research Award
Investigator: Selina Chen-Kiang
Amount: $200,000
Year awarded: 2007
Cereblon Control Of IMiD Function
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Alexander Stewart
Amount: $200,000
Year awarded: 2011
Characterization Of Phospho-Protein Networks In Myeloma
University Health Network
Senior Research Award
Investigator: Suzanne Trudel
Amount: $100,000
Year awarded: 2006
Characterizing Lethal And Drug-sensitizing Kinome Targets In Myeloma
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Rodger Tiedemann
Amount: $75,000
Year awarded: 2007
Chimeric Antigen Receptor Modified T Cells For Multiple Myeloma
Memorial Sloane-Kettering Cancer Center
Research Fellow Award
Investigator: Eric Smith
Amount: $75,000
Year awarded: 2014
Chromatin Writers, Readers And Erasers In Multiple Myeloma
Northwestern University Chicago
Epigenetics Program Project Grant
Investigator: Jonathan Licht
Amount: $1,500,000
Year awarded: 2013
Combination Therapies Targeting Proteasome, Mitochondria And NF-kappa B
Dana Farber Cancer Institute
Validation of Novel Combinations
Investigator: Dharminder Chauhan
Amount: $100,000
Year awarded: 2006
Combination Of PARP And Proteasome Inhibitors In Multiple Myeloma
University of Calgary
Senior Research Award
Investigator: Nizar Bahlis
Amount: $200,000
Year awarded: 2011
Combination Of Drugs And Radiation For Improved Therapy Of Multiple Myeloma
Mayo Clinic Rochester
Senior Research Award
Investigator: Apollina Goel
Amount: $100,000
Year awarded: 2006
Combined Therapy Of Bortezomib And BMS-345541 In A Myeloma Mouse Model
Moffitt Cancer Center and Research Institute
Validation of Novel Combinations
Investigator: Zhi-Wei Li
Amount: $99,936
Year awarded: 2006
Combining IGF-1R And HDAC Inhibitors In MM Models In Vitro And In Vivo
Vrije Universiteit Brussel
Validation of Novel Combinations
Investigator: Karin Vanderkerken
Amount: $100,000
Year awarded: 2007
Combining Tumor Vaccines With Adoptive Immunotherapy In Myeloma
Johns Hopkins University
Validation of Novel Combinations
Investigator: Ivan Borrello
Amount: $100,000
Year awarded: 2006
Comparative Oncogenomic To Identify Myeloma Progression Events
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Marta Chesi
Amount: $200,000
Year awarded: 2008
Consequences Of KDM6A/UTX Loss In Multiple Myeloma
Translational Genomics Research Institute
Target Credentialing Award
Investigator: Jonathan Keats
Amount: $250,000
Year awarded: 2010
Define CKS1B Signaling Pathways In Myeloma: Therapeutic Implication
University of Arkansas
Senior Research Award
Investigator: Fenghuang Zhan
Amount: $200,000
Year awarded: 2008
Defining Role Of Wnt Signaling In Multiple Myeloma: Therapeutic Implication
University of Arkansas
Senior Research Award
Investigator: Ya-Wei Qiang
Amount: $96,821
Year awarded: 2006
Delineation Of Differential Role Of Canonical & Non-canonical NF-kB Pathway
Dana Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima
Amount: $200,000
Year awarded: 2007
Determining The Mutational Profile Of Circulting Multiple Myeloma Cells
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jens Lohr
Amount: $75,000
Year awarded: 2014
Determining The Role Of The Histone Demethylase Gene JMJD1C In Myeloma
The Translational Genomics Research Institute
Research Fellow Award
Investigator: Bodour Salhia
Amount: $75,000
Year awarded: 2011
Development Of Cyclin D2 Inhibitors For Treatment Of Multiple Myeloma
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Alexander Stewart
Amount: $100,000
Year awarded: 2006
Development Of Novel Types Of Proteasome Inhibitors That Regulate Substrate
Harvard Medical School
Senior Research Award
Investigator: Alfred Goldberg
Amount: $200,000
Year awarded: 2008
Development Of Allosteric Proteasome Inhibitors For The Treatment Of MM
Michigan State University
Senior Research Award
Investigator: Jetze Tepe
Amount: $200,000
Year awarded: 2010
Development Of Combination Regimens Based On Histone Deacetylase Inhibitors
Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Constantine Mitsiades
Amount: $200,000
Year awarded: 2010
Development Of Preclinical Humanizeed Mouse Model Of Multiple Myeloma
The Jackson Laboratory
Research Fellow Award
Investigator: Mohit Verma
Amount: $75,000
Year awarded: 2014
Development Of Therapeutic Inhibitors For Treatment Of Multiple Myeloma.
The Hospital for Sick Children
Senior Research Award
Investigator: Chaim Roifman
Amount: $200,000
Year awarded: 2010
Effects Of IMiDs On Granulocytic Maturation
University of Pittsburgh
Senior Research Award
Investigator: Suzanne Lentzsch
Amount: $200,000
Year awarded: 2009
Effects Of JS-K, A GST Based NO Generator, On MM: Therapeutic Implications
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Tanyel Kiziltepe Bilgicer
Amount: $75,000
Year awarded: 2006
Elucidation Of Therapeutic Targets In MMSET-associated Myeloma
Northwestern University Chicago
Target Credentialing Award
Investigator: Jonathan Licht
Amount: $250,000
Year awarded: 2010
Engineering T Cell Therapy For Multiple Myeloma
Fred Hutchinson Cancer Research Center
Senior Research Award
Investigator: Edus Warren
Amount: $200,000
Year awarded: 2011
Epigenetic Deregulation By The Multiple Myeloma SET Domain Protein
Northwestern University Chicago
Research Fellow Award
Investigator: Eva Martinez
Amount: $75,000
Year awarded: 2008
Epigenetic Deregulation By Loss Of The Histone Demehtylase UTX In MM
Northwestern University Chicago
Research Fellow Award
Investigator: Teresa Ezponda-Itoiz
Amount: $100,000
Year awarded: 2014
Erastin Analogs As Anti-myeloma Agents
Dana Farber Cancer Institute
Senior Research Award
Investigator: Constantine Mitsiades
Amount: $200,000
Year awarded: 2008
Erythropoietin As An Anti-Multiple Myeloma Immunomodulating Agent
Tel Aviv University
Senior Research Award
Investigator: Drorit Neumann
Amount: $200,000
Year awarded: 2010
Establishment Of A Panel Of Diverse Human Myeloma Cell Lines
Mayo Clinic Rochester
Cell Line Development Award
Investigator: Diane Jelinek
Amount: $100,000
Year awarded: 2006
Evaluating The In Vitro And In Vivo Effects Of Targeting IL-17 In Myeloma
Boston VA Research Institute
Senior Research Award
Investigator: Rao Prabhala
Amount: $200,000
Year awarded: 2009
Evaluation Of Novel STAT3 Inhibitors In Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Erik Nelson
Amount: $200,000
Year awarded: 2007
Evaluation Of P97 As A Potential Target In Multiple Myeloma
California Institute of Technology
Research Fellow Award
Investigator: Tsui-Fen Chou
Amount: $75,000
Year awarded: 2008
Exploring The Role Of UCH-L1 In The Pathogenesis Of Myeloma
Mayo Clinic Rochester
Senior Research Award
Investigator: Paul Galardy
Amount: $200,000
Year awarded: 2010
Forward Chemical Genetic Approach To Protein Catabolism In Multiple Myeloma
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Sridevi Ponduru
Amount: $75,000
Year awarded: 2007
From Laboratory To Clinic; Dimethylaminoparthenolide (DMAPT) In Myeloma
Indiana University Indianapolis
Validation of Novel Combinations
Investigator: Attaya Suvannasankha
Amount: $100,000
Year awarded: 2007
GFI-1 Suppression Of Osteoblast Differentiation In Myeloma
University of Pittsburgh
Senior Research Award
Investigator: G. David Roodman
Amount: $200,000
Year awarded: 2009
Generation Of Cell Lines From Primary Multiple Myeloma And MGUS Tumors
National Cancer Institute
Cell Line Development Award
Investigator: Michael Kuehl
Amount: $73,600
Year awarded: 2006
Genetic Screen To Identify Wnt Target Genes To Treat Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Ruben Carrasco
Amount: $200,000
Year awarded: 2007
Genomic Changes In Plasma Cell Transformation To Myeloma In Vivo
German Cancer Research Center
Senior Research Award
Investigator: Kari Hemminki
Amount: $200,000
Year awarded: 2014
Genomic And Functional Characterization Of P53 Pathway In MM
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Wee Chng
Amount: $75,000
Year awarded: 2006
Glycosphingolipid Inhibitors In The Treatment Of Multiple Myeloma
Imperial College of Science
Validation of Novel Combinations and Novel Compounds
Investigator: Anastasios Karadimitris
Amount: $196,433
Year awarded: 2010
HDAC Inhibitors And BH3 Mimetics In Resistant/refractory Multiple Myeloma
Virginia Commonwealth University
Senior Research Award
Investigator: Steven Grant
Amount: $200,000
Year awarded: 2010
Harnessing Anti-SOX2 T Cells In Myeloma: Preclinical Studies
Yale University
Senior Research Award
Investigator: Madhav Dhodapkar
Amount: $200,000
Year awarded: 2009
Heparanase As A Target For Myeloma Treatment
Hadassah Medical Organization
Research Fellow Award
Investigator: Eyal Zcharia
Amount: $75,000
Year awarded: 2008
Heparanase As A Therapeutic Target For Regulation Of Myeloma Bone Disease
The University of Alabama at Birmingham
Senior Research Award
Investigator: Yang Yang
Amount: $200,000
Year awarded: 2011
Heparanase Inhibitor As Anti-metastatic Therapy For Myeloma
University of Alabama at Birmingham
Research Fellow Award
Investigator: Vishnu Prakash Ramani
Amount: $75,000
Year awarded: 2009
High Throughput Exon-scanning Of Kinome In Multiple Myeloma
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Keith Stewart, MD
Amount: $100,000
Year awarded: 2006
How Do BLMP1/PRDM1 And XBP1 Act As Tumor Suppressors In Multiple Myeloma
The Walter and Eliza Hall Institute of Medical Research
Senior Research Award
Investigator: Stephen Nutt
Amount: $200,000
Year awarded: 2014
Identification Of Novel Targets For T-Cell Immunotherapy Of Myeloma
Fred Hutchinson Cancer Research Center
Research Fellow Award
Investigator: Larry Anderson
Amount: $75,000
Year awarded: 2006
Identification Of Therapeutic Targets In The Non-Canonical NF-kB Pathway
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Jonathan Keats
Amount: $75,000
Year awarded: 2007
Identification Of Molecular Targets In Myeloma Microenvironments
University of Arkansas
Tumor Microenvironment Award
Investigator: Ya-Wei Qiang
Amount: $249,987
Year awarded: 2010
Identifying DKK1 As A Novel And Widely Expressed Tumor Antigen In MM
University of Texas
Research Fellow Award
Investigator: Jianfei Qian
Amount: $75,000
Year awarded: 2006
Identifying Ubiquitin Ligase Subtstrates Important For Myeloma Progression
University of California San Francisco
Senior Research Award
Investigator: David Toczyski
Amount: $200,000
Year awarded: 2014
Identifying Therapeutic Targets For FGFR3-associated MM
The Regents of the University of California
Senior Research Award
Investigator: Leslie Thompson
Amount: $200,000
Year awarded: 2006
Immunotherapy After ASCT For MM Using MAGE-A3/Poly-ICLC-primed T-cells
The University of Maryland
Senior Research Award
Investigator: Aaron Rapoport
Amount: $200,000
Year awarded: 2013
Impact Of HDAC6 Inhibition By ACY1215 And Bortezomib On MM Bone Disease
Massachusetts General Hospital
Research Fellow Award
Investigator: Eda Homare
Amount: $75,000
Year awarded: 2011
Improved Therapeutics: Targeting Sdc1/Integrin Pathways With SSTN
University of Wisconsin Madison
Research Fellow Award
Investigator: Valerie Trapp
Amount: $75,000
Year awarded: 2011
In-vivo Validation Of Novel Anti Myeloma Therapies
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Marta Chesi
Amount: $200,000
Year awarded: 2009
Induction Of Myeloma Cell Susceptibility To NK Cells
Dana Farber Cancer Institute
Senior Research Award
Investigator: Roberto Bellucci
Amount: $200,000
Year awarded: 2010
Inhibition Of The Autophagic Survival Response To Enhance Chemotherapy
University of Arizona
Validation of Novel Combinations and Novel Compounds
Investigator: Terry Landowski
Amount: $200,000
Year awarded: 2008
Integrin Regulation Of Multiple Myeloma Trafficking
Dana Farber Cancer Institute
Senior Research Award
Investigator: Irene Ghobrial
Amount: $200,000
Year awarded: 2009
Investigating CDH2 Function In Myeloma Plasma Cells And Myeloma Stem Cells
University of Arkansas
Research Fellow Award
Investigator: James Stewart
Amount: $75,000
Year awarded: 2007
Investigating The Anti-Myeloma Effects Of Clioquinol
University Health Network
Research Fellow Award
Investigator: Mahadeo Sukhai
Amount: $75,000
Year awarded: 2009
Investigation Of TP53-regulated MicroRNAs And MRNAs In Multiple Myeloma
University of Arkansas
Research Fellow Award
Investigator: Wei Xiong
Amount: $75,000
Year awarded: 2008
Is N-cadherin Expression A Prognostic Indicator In Multiple Myeloma?
Institue of Medical and Veterinary Science
Research Fellow Award
Investigator: Kate Vandyke
Amount: $75,000
Year awarded: 2011
KIR-Ligand Mismatched Natural Killer Cell Therapy For Myeloma
University of Arkansas
Senior Research Award
Investigator: Frits van Rhee
Amount: $189,862
Year awarded: 2006
Macrophages Protect Myeloma Cells From Chemotherapy Drug-induced Apoptosis
University of Texas
Research Fellow Award
Investigator: Yuhuan Zheng
Amount: $75,000
Year awarded: 2010
Measuring The Apoptotic Preset As A Predictor Of Chemosensitivity
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Triona Ni Chonghaile
Amount: $75,000
Year awarded: 2010
Mechanism And Efficacy Of Cyproheptadine As A Novel Anti-myeloma Agent
University Health Network
Senior Research Award
Investigator: Aaron Schimmer
Amount: $200,000
Year awarded: 2007
Mechanism Of Anti-tumor Effects Induced By Allogeneic Donor-cell Rejection
Massachusetts General Hospital
Research Fellow Award
Investigator: Toshiki Saito
Amount: $75,000
Year awarded: 2007
Mechanisms Of Lenalidomide Resistance
University of Texas
Senior Research Award
Investigator: Robert Orlowski
Amount: $200,000
Year awarded: 2010
Mechanisms Of Transformation In T(4;14) + Myeloma
Washington University in St. Louis
Senior Research Award
Investigator: Michael Tomasson
Amount: $200,000
Year awarded: 2011
Minimal Residual Disease To Better Characterize Multiple Myeloma Response And Detect Early Relapse
Ospedale-Molinette
Diagnostic Investment Award
Investigator: Antonio Palumbo
Amount: $500,000
Year awarded: 2010
Molecular Mechanisms Of Intrinsic Resistance Of Myeloma Cells To Bortezomib
Dartmouth College
Senior Research Award
Investigator: Alexei Kisselev
Amount: $200,000
Year awarded: 2010
Multi-Targeted Kinase Inhibition-Based Combination Strategies In Myeloma
Dana Farber Cancer Institute
Validation of Novel Combinations
Investigator: Constantine Mitsiades
Amount: $100,000
Year awarded: 2006
Multiple Myeloma Therapeutics Based On The Natural HDACi Largazole
Colorado State University
Senior Research Award
Investigator: Robert Williams
Amount: $200,000
Year awarded: 2009
Multiple Myeloma And Bone: Understanding The Destruction
Mayo Clinic - Rochester
Research Fellow Award
Investigator: Matthew Drake
Amount: $75,000
Year awarded: 2007
Non-Genotoxic Activators Of P53 As Therapy For Multiple Myeloma
Mayo Clinic Rochester
Validation of Novel Combinations
Investigator: Shaji Kumar
Amount: $87,825
Year awarded: 2006
Novel Combination Therapies For Mutiple Myeloma
University of Alabama at Birmingham
Senior Research Award
Investigator: Yang Yang
Amount: $200,000
Year awarded: 2007
Novel Natural Products With Potential Therapeutic Uses In Multiple Myeloma
Mayo Clinic - Rochester
Research Fellow Award
Investigator: Jennifer Tibodeau
Amount: $75,000
Year awarded: 2006
Novel Polymeric Targeting Nanocarrier For The Treatment Of Multiple Myeloma
The Regents of the University of California
Research Fellow Award
Investigator: Juntao Luo
Amount: $75,000
Year awarded: 2007
Novel Stromal Factors Driving Bortezomib-resistant NF-kappaB Activity In MM
University of Wisconsin Madison
Senior Research Award
Investigator: Shigeki Miyamoto
Amount: $200,000
Year awarded: 2011
Novel Treatment Approaches To Target The RARa2 Positive Myeloma Cell
University of Utah
Senior Research Award
Investigator: Fenghuang Zhan
Amount: $200,000
Year awarded: 2010
Novel Regulatory Properties Of Proteasomes In Multiple Myeloma
Harvard Medical School
Research Fellow Award
Investigator: Nikolay Kukushkin
Amount: $75,000
Year awarded: 2013
Obesity-associated Multiple Myeloma: Targeting The AMPK Pathway
University of Texas Health Science Center at San Antonio
Research Fellow Award
Investigator: Edward Medina
Amount: $75,000
Year awarded: 2012
On The Role Of CJun And CAbl In Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Klaus Podar
Amount: $200,000
Year awarded: 2006
Osteoblast And Their Mesenchymal Progenitors In Myeloma.
University of Arkansas
Research Fellow Award
Investigator: Igor Entin
Amount: $75,000
Year awarded: 2007
Overcoming Lenalidomide Resistance In Multiple Myeloma
The University of Texas Md Anderson Cancer Center
Research Fellow Award
Investigator: Chad Bjorkland
Amount: $75,000
Year awarded: 2011
Overcoming Drug Resistance In MM: Development Of An In Vivo Mouse Model
University of Wuerzburg
Senior Research Award
Investigator: Ralf Bargou
Amount: $200,000
Year awarded: 2008
PARP Inhibitor As Novel Therapeutic Approach In Multiple Myeloma
University of Calgary
Research Fellow Award
Investigator: Ernesta Paola Neri
Amount: $75,000
Year awarded: 2010
Pathogen Discovery And Host-Viral Relationships In Multiple Myeloma
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Akinyemi Ojesina
Amount: $75,000
Year awarded: 2011
Phosphoproteomic Analysis Of NF-kappaB In MM
Michigan State University
Senior Research Award
Investigator: Jetze Tepe
Amount: $200,000
Year awarded: 2008
Pre-clinical Study Of Daratumumab In Auto-SCT For MM And AL Amyloidosis
Tufts Medical Center
Research Fellow Award
Investigator: Chakra Chaulagain
Amount: $75,000
Year awarded: 2013
Pre-clinical Validation Of IL-6 For Translational Myeloma Research
University of Iowa
Senior Research Award
Investigator: Siegfried Janz
Amount: $200,000
Year awarded: 2009
Preclinical Investigation Of ABT-737 In Treatment Of Multiple Myeloma
University Health Network
Validation of Novel Combinations
Investigator: Xiao-Yan Wen
Amount: $100,000
Year awarded: 2006
Proteomic Profiling In Multiple Myeloma
University of Arkansas
Proteomics Award
Investigator: Ricky Edmonson
Amount: $750,000
Year awarded: 2007
Quantification Of Circulating Tumor Specific DNA In Multiple Myeloma
Johns Hopkins University
Diagnostic Investment Award
Investigator: William Matsui
Amount: $500,000
Year awarded: 2010
RAP-011, A Novel Activin Antagonist In The Treatment Of Myeloma
Massachusetts General Hospital
Validation of Novel Combinations and Novel Compounds
Investigator: Noopur Raje
Amount: $200,000
Year awarded: 2008
Radioimmunotherapy For Multiple Myeloma
Fred Hutchinson Cancer Research Center
Research Fellow Award
Investigator: Damian Green
Amount: $75,000
Year awarded: 2009
Refinement Of The XBP-1 Mouse Model Of Multiple Myeloma
Dana Farber Cancer Institute
Animal Model Development Award
Investigator: Yaoqi Wang
Amount: $200,000
Year awarded: 2007
Refining Mechanisms Of Resistance To Velcade: Clinical Implication
Dana Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima
Amount: $100,000
Year awarded: 2006
Regulation Of Multiple Myeloma By Myeloid Cells
Moffitt Cancer Center and Research Institute
Tumor Microenvironment Award
Investigator: Yulia Nefedova
Amount: $250,000
Year awarded: 2010
Reversing Malignant Reprogramming Of Multiple Myeloma Cancer Stem Cells
University of California San Diego
Research Fellow Award
Investigator: Leslie Robertson
Amount: $75,000
Year awarded: 2013
Role Of Osteoclasts In The Regulation Of T-cell Immunity In Myeloma
University of Texas
Research Fellow Award
Investigator: Haiyan Li
Amount: $75,000
Year awarded: 2009
Role Of SLRPs In The Anti-myeloma Response Of Osteoblasts
University of Arkansas
Senior Research Award
Investigator: Shmuel Yaccoby
Amount: $99,759
Year awarded: 2006
Role Of Calcium In Mediating C-HYD1 And HYD1 Induced Cell Death In MM
Moffitt Cancer Center and Research Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Lori Hazlehurst
Amount: $200,000
Year awarded: 2010
Role Of Osteoclasts In Immunosuppression In Myeloma
Cleveland Clinic Foundation
Senior Research Award
Investigator: Qing Yi
Amount: $200,000
Year awarded: 2014
Screening For Small Molecule Inhibitors Of MM Within Its Microenvironment
Massachusetts General Hospital
Research Fellow Award
Investigator: Shrikanta Chattopadhyay
Amount: $75,000
Year awarded: 2009
Small Molecule Inhibitors Of STAT3 In Multiple Myeloma
Princess Margaret Hospital
Research Fellow Award
Investigator: Victor Jimenez-Zepeda
Amount: $75,000
Year awarded: 2011
Stem Cell Rejection To Induce Anti-tumor Immunity
Massachusetts General Hospital
Senior Research Award
Investigator: Megan Sykes
Amount: $200,000
Year awarded: 2007
Studying The Myeloma Niche By 3D Mesenchymal Stem Cell-based System
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jana Jakubikova
Amount: $75,000
Year awarded: 2012
Synergistic Combinations Of Targeted Agents For Myeloma
Emory University
Validation of Novel Combinations
Investigator: Sagar Lonial
Amount: $100,000
Year awarded: 2006
Synergistic Effects Of PS-341 (Velcade) And BX471 On Multiple Myeloma
University of Pittsburgh
Validation of Novel Combinations
Investigator: Suzanne Lentzsch
Amount: $100,000
Year awarded: 2006
Synergy Of Aplidin And LBH589 With Conventional Anti-myeloma Treatments
Centro de Investigacion del Cancer
Validation of Novel Combinations
Investigator: Atanasio Pandiella
Amount: $100,000
Year awarded: 2006
TH17 Cytokines In Myeloma: Immunotherapeutic Targets
Boston VA Research Institute
Research Fellow Award
Investigator: Rao Prabhala
Amount: $75,000
Year awarded: 2008
TJP1: A Novel Modulator Of Proteasome Inhibitor Sensitivity And Resistance
University of Texas
Research Fellow Award
Investigator: Xingding Zhang
Amount: $75,000
Year awarded: 2013
Targeted Inhibition Of JAK-STAT Signalling To Modify MM Drug Resistance
Monash University
Validation of Novel Combinations and Novel Compounds
Investigator: Andrew Spencer
Amount: $197,308
Year awarded: 2010
Targeted Neutralization Of Regulatory T-cells To Improve Cancer Therapy
University Medical Center Utrecht
Senior Research Award
Investigator: Tuna Mutis
Amount: $200,000
Year awarded: 2011
Targeting Autophagy In Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: James E. Bradner, MD
Amount: $200,000
Year awarded: 2010
Targeting CD40 Therapy Using Humanized Mabs Alone Or With ImiD3 In Human Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Yu-Tzu Tai
Amount: $100,000
Year awarded: 2006
Targeting DEPTOR In Multiple Myeloma
Brentwood Biomedical Research Institute
Research Fellow Award
Investigator: Yonghui Yang
Amount: $75,000
Year awarded: 2011
Targeting Deubiquitylase Enzyme USP-7 As Therapy In Myeloma
Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Dharminder Chauhan
Amount: $200,000
Year awarded: 2008
Targeting Met Receptor Tyrosine Kinase In Multiple Myeloma
University of Texas
Senior Research Award
Investigator: Christine Stellhecht
Amount: $200,000
Year awarded: 2011
Targeting UBC13 For Multiple Myeloma Treatment
Burnham Institute for Medical Research
Research Fellow Award
Investigator: Charitha Madiraju
Amount: $75,000
Year awarded: 2010
Targeting Vascular Endothelial Growth Factor For Treatment Of Myeloma
Mayo Clinic Rochester
Senior Research Award
Investigator: Shaji Kumar
Amount: $200,000
Year awarded: 2007
Targeting Wnt Signaling In Myeloma Using Stabilized Alpha-Helices Of BCL9
Dana Farber Cancer Institute
Senior Research Award
Investigator: Ruben Carrasco
Amount: $200,000
Year awarded: 2008
Targeting Wnt Signaling Network To Enhance Chemotherapy In MM
Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Yulia Nefedova
Amount: $200,000
Year awarded: 2009
Targeting A Third NF-KB Pathway For Anti-myeloma Drug Development.
University of Wisconsin Madison
Senior Research Award
Investigator: Shigeki Miyamoto
Amount: $200,000
Year awarded: 2008
Targeting P90RSK By A Highly Specific Inhibitor Fmk In Multiple Myeloma
Emory University
Validation of Novel Combinations
Investigator: Jing Chen
Amount: $100,000
Year awarded: 2006
Targeting Protein-protein Interactions In Myeloma TORC Complexes
Brentwood Biomedical Research Institute
Senior Research Award
Investigator: Alan Lichtenstein
Amount: $200,000
Year awarded: 2011
Targeting The MUC1 Oncoprotein In Multiple Myeloma
Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Donald Kufe
Amount: $200,000
Year awarded: 2008
Targeting The SCF/skp2 Pathway For The Treatment Of Multiple Myeloma
University of North Carolina at Chapel Hill
Research Fellow Award
Investigator: Qing Chen
Amount: $75,000
Year awarded: 2006
Targeting The Unfolded Protein Response For Cancer Therapy
Stanford University
Senior Research Award
Investigator: Albert Koong
Amount: $200,000
Year awarded: 2010
Targeting Type 1 IFN And TRAIL To MM Using Anti-CD138 Fusion Proteins
The Regents of the University of California
Senior Research Award
Investigator: Sherie Morrison
Amount: $200,000
Year awarded: 2010
The NFKB2-IL10 Pathway In Multiple Myeloma Pathogenesis
Medical College of Georgia Research Institute
Research Fellow Award
Investigator: Brian McCarthy
Amount: $75,000
Year awarded: 2010
The Role Of EMMPRIN In Myeloma Cell Biology And Disease Progression
Mayo Clinic
Senior Research Award
Investigator: Diane Jelinek
Amount: $200,000
Year awarded: 2011
The Role Of MDSCs In The Immune Escape Of Multiple Myeloma
Moffitt Cancer Center and Research Institute
Research Fellow Award
Investigator: Indu Ramachandran
Amount: $75,000
Year awarded: 2012
The Role Of MMSET In Regulation Of Chromatin Structure In T(4;14)+ Myeloma
Northwestern University Chicago
Research Fellow Award
Investigator: Relja Popovic
Amount: $75,000
Year awarded: 2011
The Role Of NFkB Pathway Mutations In Multiple Myeloma
Mayo Clinic Scottsdale
Senior Research Award
Investigator: Leif Bergsagel
Amount: $200,000
Year awarded: 2007
The Role Of Selectins In Multiple Myeloma
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Abdel Kareem Azab
Amount: $75,000
Year awarded: 2008
The Role Of C-FLIP In Multiple Myeloma
Indiana University Indianapolis
Research Fellow Award
Investigator: Attaya Suvannasankha
Amount: $75,000
Year awarded: 2007
The Activity Of Novel PI3K Inhibitors In Myeloma
Institute of Cancer Queen Mary University of London
Validation of Novel Combinations and Novel Compounds
Investigator: Simon Joel
Amount: $199,984
Year awarded: 2008
The Function Of Irf4 And Blimp1 In Normal And Malignant Plasma Cells
The Walter and Eliza Hall Institute of Medical Research
Senior Research Award
Investigator: Stephen Nutt
Amount: $200,000
Year awarded: 2011
The Humanized Multiple Myeloma Mouse Model
University Medical Center Utrecht
Senior Research Award
Investigator: Anton Martens
Amount: $200,000
Year awarded: 2010
Therapeutic Targeting Of Ire1/XBP-1 In Malignant B Cells
Stanford University
Research Fellow Award
Investigator: Douglas Feldman
Amount: $75,000
Year awarded: 2006
Therapeutic Targeting Of Notch And Bcl-2/bcl-xL In Multiple Myeloma
Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Yulia Nefedova
Amount: $200,000
Year awarded: 2007
The Role Of SCF Ubiquitin Ligases In Multiple Myeloma
New York University School of Medicine
Senior Research Award
Investigator: Michele Pagano
Amount: $200,000
Year awarded: 2007
The Role Of XBP1s In Multiple Myeloma Microenvironment
University of Pittsburgh
Tumor Microenvironment Award
Investigator: Hongjiao Ouyang
Amount: $249,950
Year awarded: 2010
The Role Of Hypoxia In The Micro-residual Disease In Multiple Myeloma
Washington University in St. Louis
Research Fellow Award
Investigator: Barbara Muz
Amount: $75,000
Year awarded: 2013
The Role Of Survival Proteins In Multiple Myeloma Development
The Walter and Eliza Hall Institute of Medical Research
Research Fellow Award
Investigator: Victor Peperzak
Amount: $75,000
Year awarded: 2010
Tissue-Based Array Classification Of Multiple Myeloma
University of Calgary
Research Fellow Award
Investigator: Alex Klimowicz
Amount: $75,000
Year awarded: 2008
Towards MM Immunotherapy By Adoptive Transfer Of Idiotype-specific T Cells
University of Oslo
Senior Research Award
Investigator: Bjarne Bogen
Amount: $200,000
Year awarded: 2007
Towards Small Molecule GRK6 Inhibitors As Therapuetics For Multiple Myeloma
University Health Network
Research Fellow Award
Investigator: Kim Chan Chung
Amount: $75,000
Year awarded: 2014
Transgenic Mouse Model Of Drug Development For Multiple Myeloma
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Michael Sebag
Amount: $75,00
Year awarded: 2006
Transient Lymphodepletion And PD-1/PD-L1 Blockade To Treat Myeloma
Medical College of Wisconsin
Senior Research Award
Investigator: Bryon Johnson
Amount: $200,000
Year awarded: 2012
Translation Studies Of IGFS/IGF-1R
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Constantine Mitsiades
Amount: $100,000
Year awarded: 2006
Treating Multiple Myeloma Using Anti-CD138 Genetically Fused To Type 1 IFN
The Regents of the university of California
Senior Research Award
Investigator: Sherie Morrison
Amount: $200,000
Year awarded: 2013
Treatment Of Multiple Myeloma With A Humanized Mononclonal Antibody
Temple University
Senior Research Award
Investigator: Robert Colman
Amount: $100,000
Year awarded: 2006
Tryptophan Metabolism In The Immune Dysregulation Of Multiple Myeloma
University of Turin
Research Fellow Award
Investigator: Francesca Fiore
Amount: $75,000
Year awarded: 2007
Type I MAGE MRNA-pulsed Dendritic Cell Vaccines For Multiple Myeloma
New York University School of Medicine
Validation of Novel Combinations
Investigator: Hearn Cho
Amount: $100,000
Year awarded: 2006
UTX Regulates Spontaneous And Bortezomib-induced Apoptosis In Myeloma
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Ryan Holzer
Amount: $75,000
Year awarded: 2012
Understanding The Myeloid Microenvironment In Multiple Myeloma
Health Research Incorporated
Tumor Microenvironment Award
Investigator: Kelvin lee
Amount: $250,00
Year awarded: 2010
Understanding The Resistant Plasma Cell: The Dream Of Curing Myeloma
Fundacion de Investigacion de Cancer
Research Fellow Award
Investigator: Bruno Paiva
Amount: $75,000
Year awarded: 2012
Vaccination And T Cell Therapy Using DC/Myeloma Fusions With Transplant
Beth Israel Deaconess Medical Center
Senior Research Award
Investigator: David Avigan
Amount: $200,000
Year awarded: 2008
Validating MiR-30 As A Novel Therapeutic Tool For Multiple Myeloma
Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jianjun Zhao
Amount: $75,000
Year awarded: 2011
Validation Of Potential Driver Mutations In Multiple Myeloma Cohort
Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Jan Egan
Amount: $75,00
Year awarded: 2011
Validation Of An Anti-JAG2 MAb For Treatment Of Multiple Myeloma
Health Research Incorporated
Senior Research Award
Investigator: Lionel Coignet
Amount: $200,000
Year awarded: 2007
Validation Of Pyrimidinetriones As Potential Therapy For Multiple Myeloma
Cornell University
Validation of Novel Combinations and Novel Compounds
Investigator: Hsiou-Chi Liou
Amount: $200,000
Year awarded: 2008
Validation Of Withaferin A As An Anti-myeloma Compound
Universiteit Gent
Validation of Novel Combinatoins and Novel Compounds
Investigator: Wim Vanden Berghe
Amount: 199,088
Year awarded: 2008
WNT Receptors: Targets To Disrupt MM Interaction With The Microenvironment
Fondazione Centro San Raffaele Del Monte Tabor
Research Fellow Award
Investigator: Michela Frenquilli
Amount: 75,000
Year awarded: 2011
Whole Transcriptome RNA Sequencing Of Multiple Myeloma Tumors Using Next Generation Sequencing Technologies
Translational Genomics Research Institute
Genomics Award
Investigator: John Carpten
Amount: 672,000
Year awarded: 2010
Anti-KIR And Lenalidomide Enhances The NK Cell Vs Multiple Myeloma Effect
Ohio State University Research Foundation
Research Fellow Award
Investigator: Don Benson
Amount: $75,000
Year awarded: 2009
P62 Signaling As A Therapeutic Target For Multiple Myeloma
University of Pittsburgh
Senior Research Award
Investigator: Noriyoshi Kurihara
Amount: $200,000
Year awarded: 2009
A Gene Therapy Approach For Multiple Myeloma
Mayo Clinic
Fellows' Award
Investigator: David Dingli, MD
Year awarded: 2001
AKT-mediated Regulation Of Sensitization Of Multiple Myeloma Cells To MTOR Inhibitors
West LA VA Medical Center
Fellows' Award
Investigator: Patrick Frost, PhD
Year awarded: 2005
AKT/p70S6K/4E-BPI Cascade In Multiple Myeloma
VA West LA Hospital- UCLA Medical School
Senior Research Award
Investigator: Alan Lichtenstein, MD
Year awarded: 2000
A Model For The In Vivo Growth Of Multiple Myeloma In The Bone Marrow Microenvironment
Dana Farber Cancer Institute
Fellows' Award
Investigator: Richard LeBlanc, MD
Year awarded: 2001
A Novel Multiplex Drug Screening Assay (MDSA) Of Compounds Related To Multiple Myeloma
Year awarded:
Adhesion-mediated Effects On MTOR In MM Cells
UCLA West LA VA Medical Center
Fellows' Award
Investigator: Bao Hoang, PhD
Year awarded: 2004
Adoptive T-Cell Therapy In Multiple Myeloma
University Hospital, The Netherlands
Senior Research Award
Investigator: Henk Lokhorst, MD, PhD
Year awarded:
Analysis Of CYP1B1 Specific T Cells In Multiple Myeloma Patients
Dana Farber Cancer Institute
Fellows' Award
Investigator: Britta Maecker, MD
Year awarded: 2000
Angiogenic Growth Factors As A Therapeutic Target In Myeloma
University of Arizona
Senior Research Award
Investigator: William T. Bellamy, PhD
Year awarded:
Anti-Apoptosis Mechanisms Of Mcl-1 In Multiple Myeloma
University of Maryland, Baltimore
Fall Senior Research Award
Investigator: Robert G. Fenton, MD, PhD
Year awarded: 2002
Antigen Induced Myeloma
Mayo Clinic Arizona
Fellows' Award
Investigator: Maurizio Affer, PhD
Year awarded: 2005
Apoptosis Of Multiple Myeloma Cells Induced By FasL And TRAIL/Apo2L: Therapeutic Applications
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Nicholas Mitsiades, MD, PhD
Year awarded: 2001
Apoptotic And Survival Proteins As Novel Therapeutic Targets In Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Dharminder Chauhan, PhD
Year awarded: 2000
Arsenic Trioxide And Ascorbic Acid As Treatment For Multiple Myeloma
University of Miami School of Medicine
Senior Research Award
Investigator: Lawrence H. Boise, PhD
Year awarded: 2001
Augmentation Of Anti-myeloma Activity Of Conventional/Novel Agents By Inhibition Of Akt Using A Novel Alkyl-phospholipid, Perifosine
Dana Farber Cancer Institute
RFA: Translational Research
Investigator: Teru Hideshima, MD, PhD
Year awarded: 2005
B1 Integrin-Initated Signaling Events Regulate The Subcellular Localization Of C-FLIP L Following Adhesion To Fibronectin, Protecting Adhered MM Cells From CD95-Mediated Apoptosis
H. Lee Moffitt Cancer Center and Research Institute
Fellows' Award
Investigator: Kenneth Shain, PhD
Year awarded: 2001
Biologic Sequelae Of CD40 Signaling In Human Multiple Myeloma
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Yu Tzu-Tai, PhD
Year awarded: 2002
Biologic Sequelae Of Interleuken-6 Induced PI3-K/Akt Signaling In Multiple Myeloma
Dana Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima, MD, PhD
Year awarded: 2001
Cataloguing The Expressed Gene Profile Of Multiple Myeloma
Princess Margaret Hospital, Canada
Senior Research Award
Investigator: Keith Stewart, MD
Year awarded: 2001
Cell Therapy Of Multiple Myeloma-Induction Of An Anti-MAGE Response
Vrije Universiteit Brussels
Senior Research Award
Investigator: Kris Thielemans, MD, PhD
Year awarded:
Characterizing The Binding Interaction Between Tamm-Horsfall Protein And Immunoglobulin Light Chains
University of Alabama at Birmingham
Senior Research Award
Investigator: Paul W. Sanders, MD
Year awarded: 2001
Checkpoint Abrogation And MEK/MAPK Inhibition: A Novel Strategy For The Treatment Of Multiple Myeloma
Virginia Commonwealth University
Senior Research Award
Investigator: Steven Grant, MD
Year awarded: 2001
Conditional Knockout Of A Putative Tumor Suppressor Gene CHC1L In Multiple Myeloma
Toronto General Research Institute / Toronto General Hospital
Fellows' Award
Investigator: Chang-Xin Shi, PhD
Year awarded: 2005
Cytolytic T Lymphocyte (CTL) Mediated Immunotherapy Of Multiple Myeloma Using Gene Modified Dendritic Cells
University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Ramesh B. Batchu, Ph.D.
Year awarded: 2002
Defining Mechanisms Of Resistance To Velcade: Clinical Implication
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima, M.D., Ph.D.
Year awarded: 2004
Defining The Role Of BAFF And APRIL In Multiple Myeloma And Its Bone Marrow Milieu: Therapeutic Implications
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Noopur Raje, MD
Year awarded: 2005
Dendritic Cell Based Vaccination For Multiple Myeloma
Duke University Medical Center
Fellows' Award
Investigator: Cristina Gasparetto, MD
Year awarded: 2001
Dendritic Cell Strategies Combined With Chemotherapy Against Multiple Myeloma
North Shore LIJ Health System
Fellows' Award
Investigator: Youzhi Tong, PhD
Year awarded: 2000
Determination Of Antigen-Specific Immunity In Myeloma Patients
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Joachim L. Schultze, MD
Year awarded: 2000
Development And Trial Of DNA Vaccines Against Multiple Myeloma
University of Southampton, UK
Senior Research Award
Investigator: F.K. Stevenson, DPhil and Francesco Forconi, MD
Year awarded: 2000
Development Of Molecularly-Based Combination Therapy For Multiple Myeloma
Dana-Farber Cancer Institute
Collaborative Program Grant
Investigator: Kenneth C. Anderson, MD
Amount: $1,500,000
Year awarded: 2004
Development Of Novel Target-based Therapies For Multiple Myeloma
Collaborative Program Grant
Year awarded: 2001
Development Of Artificial Antigen Presenting Cells For Adoptive Immunotherapy Of Multiple Myeloma
Johns Hopkins University School of Medicine
Senior Research Award
Investigator: Jonathan Schneck, MD, PhD
Year awarded: 2003
Development Of Novel Targeted Therapy For Multiple Myeloma
University of Utah - Huntsman Cancer Institute
Senior Research Award
Investigator: Ray Lee, MD, PhD
Year awarded: 2005
Dissecting The PI3K/PTEN/Akt/NF-kB Pathway In Myeloma Malignant Transformation
Georgetown University Medical School
Senior Research Award
Investigator: Weiqun Li, MD
Year awarded: 2002
Donor Lymphocyte Infusions Combined With Autologous Antigen Presenting Cells To Improve The Graft-versus-myeloma Effect
University Medical Center Utrecht
Senior Research Award
Investigator: Henk Lokhorst, MD, PhD
Year awarded: 2005
Effects Of Farnesyl Transferase Inhibitors (FTI) In Combination With Cytotoxic Chemotherapy Or Other Drugs Targeting Ras Processing On Myeloma Tumor Burden, In A SCID-hu Model Of Human Myeloma: A Preclinical Study
H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Melissa Alsina, MD
Year awarded: 2001
Effects Of HYD1 On Melphalan Sensitivity In A SCID-Hu In-vivo Multiple Myeloma Model
Moffitt Cancer Center
RFA: Translational Research
Investigator: Lori Hazlehurst, PhD
Year awarded: 2005
Endothelial Progenitor Cells And Multiple Myeloma: Prognosis And Treatment
SUNY Downstate Medical Center
Senior Research Award
Investigator: Olcay Batuman, MD
Year awarded: 2005
Epigenetic Profiling In Multiple Myeloma
The Curators of the University of Missouri-Columbia
Senior Research Award
Investigator: Huidong Shi, Ph.D.
Year awarded: 2004
Evaluation Of A Regulatory Site In The Ubiquiting-conjugating Enzyme Cdc34 As A Potential Therapeutic Target For The Treatment Of Multiple Myeloma
St. Vincent's Institute of Medical Research
Senior Research Award
Investigator: Borislav Sarcevic, BSc, PhD
Year awarded: 2005
Examining IL-8 And The Pathogenesis Of Multiple Myeloma
Mayo Clinic - Rochester
Fellows' Award
Investigator: Michael P. Kline, PhD
Year awarded: 2005
Functional Characterization Of The Multiple Myeloma SET Domain (MMSET) Protein
Mount Sinai Medical School-Mount Sinai Medical Center
Fellows' Award
Investigator: Leonardo Andres Sirulnik, MD, PhD
Year awarded: 2002
Functional Characterization Of The Multiple Myeloma Set Domain Protein
Mount Sinai School of Medicine
Fall Senior Research Award
Investigator: Jonathan D. Licht, MD
Year awarded: 2002
Functional Characterization Of MMSET In-vivo
Mayo Clinic College of Medicine
Senior Research Award
Investigator: Marta Chesi, PhD
Year awarded: 2005
Gene Expression Profile Of Vascular Endothelial Cells In Patients With Multiple Myeloma And Its Clinical Significance
SUNY-Downstate Medical Center
Senior Research Award
Investigator: Olcay Batuman, MD
Year awarded: 2001
Genetic Vaccination Against Multiple Myeloma.
Southampton University in the United Kingdom
Senior Research Award
Investigator: Freda Stevenson, DPhil
Year awarded:
Glycogen Synthase Kinase 3 As A Potential Target For Therapy In Multiple Myeloma
University of Chicago
Senior Research Award
Investigator: Amittha Wickrema, PhD
Year awarded: 2002
Heat Shock Proteins As Targets For Immunotherapy In Multiple Myeloma
The University of Texas MD Anderson Cancer Center
Senior Research Award
Investigator: Qing Yi, MD, PhD
Year awarded: 2005
High Potency Immunodominant Peptide Immunotherapy
Royal Prince Alfred Hospital, Australia
Fellows' Award
Investigator: Daniel Man-Yuen Sze, PhD
Year awarded: 2002
High Throughout Exon-scanning Of The Kinome In Multiple Myeloma
Toronto General Research Institute, University Health Network
Senior Research Award
Investigator: Jaime O. Claudio, Ph.D.
Year awarded: 2004
Id-specific T Cells In Multiple Myeloma
University of Oslo
Senior Research Award
Investigator: Bjarne Bogen, MD, PhD
Year awarded:
Identification And Characterization Of 14q32 Translocations In Patients With Monoclonal Gammopathy Of Undetermined Significance
Mayo Clinic - Rochester
Fellows' Award
Investigator: Rafael Fonseca, MD
Year awarded:
Identification Of Gene Expression Patterns Associated With Prognosis And Outcome In Multiple Myeloma
Mayo Clinic
Senior Research Award
Investigator: Diane F. Jellinek, PhD
Year awarded: 2000
Identification Of Genetic Markers During Multistep Malignant Transformation Of Multiple Myeloma
Memorial Sloane-Kettering Cancer Center
Fellows' Award
Investigator: Pulivarthi Rao, PhD
Year awarded:
Identification Of Inhibitors Of Light Chain Amyloidosis
University of Tennessee Graduate School of Medicine
Senior Research Award
Investigator: Jonathan Stuart Wall, PhD
Year awarded: 2003
Identification Of Molecular Markers That Determine PS-341 Sensitivity (or Resistance) In Multiple Myeloma
Dana Farber Cancer Institute
Fellows' Award
Investigator: Reshma Shringarpure, PhD
Year awarded: 2003
Identification Of Novel Therapeutic Targets In Multiple Myeloma
Princess Margaret Hospital, University Health Network
Senior Research Award
Investigator: A. Keith Stewart, MB.CHB, F.R.C.P.C., MBA
Year awarded: 2003
Identifying New Antigens For Targeted Therapy In Multiple Myeloma
Southampton University Hospitals
Senior Research Award
Investigator: Surinder S. Sahota, PhD
Year awarded: 2002
Idiotypic Immunization Of Multiple Myeloma Patients Using The Autologous M-protein In Combination With IL-12 Or IL-12 And GM-CSF
Karolinska Hospital, Sweden
Fellows' Award
Investigator: Anders Osterborg, MD
Year awarded:
Immune Assessment After Autotransplantation Followed By Adoptive Transfer Of Ex Vivo Costimulated Autologous T-cells In Conjunction With Pneumococcal Conjugate Vaccine Immunization For Patients With Multiple Myeloma
University of Pennsylvania
Fellows' Award
Investigator: Nichole Aqui, MD
Year awarded: 2004
Immunobiology Of Lymphohematopoietic GVH Reactions
Massachusetts General Hospital
Senior Research Award
Investigator: Megan Sykes, MD
Year awarded: 2005
Immunostimulatory DNA: Application To DNA Based Vaccines For Multiple Myeloma
University of California, San Diego
Senior Research Award
Investigator: Helen Tighe, PhD
Year awarded:
Immunotherapeutic Approach To Multiple Myeloma
Dana Farber Cancer Institute
Fellows' Award
Investigator: Toshiaki Hayashi, MD, PhD
Year awarded: 2001
Immunotherapy Of Multiple Myeloma: Reversal Of Tolerance And Improved Id-Vaccination
University of Oslo
Senior Research Award
Investigator: Bjarne Bogen, MD, PhD
Year awarded: 2002
Immunotherapy Targeting Multiple Myeloma Specific Antigens
University of Florida
Senior Research Award
Investigator: Lung-Ji Chang, Ph.D.
Year awarded: 2004
Immunotherapy With Myeloma-specific Cytotoxic T Lymphocytes
University of Arkansas for Medical Sciences
Fall Senior Research Award
Investigator: Frits van Rhee, MD, PhD
Year awarded: 2002
Inhibition Of IL-1 In The Myeloma Microenvironment
Mayo Clinic
Fall Senior Research Award
Investigator: John A. Lust, MD, PhD
Year awarded: 2002
Interleukin-6 (IL-6) Induced SHP2 Activation Mediates Resistance To Dexamethasone (Dex) &Mac246; Induced RAFTK Activation And Apoptosis In Multiple Myeloma Cells
Dana-Farber Cancer Institute
Fellows' Award
Investigator: Dharminder Chauhan, PhD
Year awarded:
Involvement Of Fanconi Anemia/BRCA DNA Repair Pathway In Acquired Melphalan Drug-resistant Myeloma Cells
H. Lee Moffitt Cancer Center
Fellows' Award
Investigator: Qing Chen, PhD
Year awarded: 2004
Is The Transcription Factor XBP-1 A Critical Target For Proteasome Inhibitors In Multiple Myeloma?
Harvard School of Public Health
Senior Research Award
Investigator: Laurie H. Glimcher, MD
Year awarded: 2002
Mechanism/s Of Osteolytic Lesions In Multiple Myeloma: The Role Of The Osteoblasts
University of Bari, Italy
Fellows' Award
Investigator: Giacomina Brunetti, PhD
Year awarded: 2005
Mechanism Of Kidney Failure In Multiple Myeloma
University of Oklahoma Health Science Center
Fellows' Award
Investigator: Satish Kumar, MD
Year awarded: 2000
Mixed Chimera Transplants Followed By Idiotype Vaccinations For Multiple Myeloma
Stanford University
Senior Research Award
Investigator: Keith E. Stockert Goldstein, MD
Year awarded:
Molecular Mechanism Of MTOR Inhibition As A Therapeutic Modality For Multiple Myeloma
University of Pittsburgh
Fellows' Award
Investigator: Yazan M. Alsayed, MD
Year awarded: 2005
Molecular Mechanisms And Synergy Between Proteasome Inhibition And Farnesyl Transferase Inhibition In Multiple Myeloma Cells
Winship Cancer Center, Emory University
Fellows' Award
Investigator: Ebenezer David, PhD
Year awarded: 2004
Mouse Myeloma Models With Targeted Chromosome 14 Deletions
Toronto General Research Institute, University Health Network, Canada
Senior Research Award
Investigator: Xiao-Yan Wen, MD, PhD
Year awarded: 2005
Myeloma-Microenvironment Interaction Dynamics: The Involvement Of Bone Cells
University of Arkansas for Medical Sciences
Senior Research Award
Investigator: Dr. Shmuel Yaccoby, PhD
Year awarded: 2001
Myeloma Vaccine Development
Toronto General Hospital
Senior Research Award
Investigator: A. Keith Stewart, MD
Year awarded:
Notch Signaling As A New Molecular Target In Multiple Myeloma
H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Dmitry I. Gabrilovich, MD, PhD
Year awarded: 2005
Optimization Of Dendritic Cell-Based Immunotherapy In Multiple Myeloma
University of Arkansas for Medical Science
Senior Research Award
Investigator: Qing Yi, MD, PhD
Year awarded: 2000
Optimization Of Dendritic Cell Preparation And MRNA Loading For Multiple Myeloma Immunotherap
Mater Medical Research Institute
Fellows' Award
Investigator: Dr Cameron Turtle, MBBS, FRACP, FRCPA
Year awarded: 2001
Potent Enhancement Of Conventional Multiple Myeloma Chemotherapy By DMC, A Novel Drug With Multifaceted Molecular Actions
University of Southern California Keck Medical School
RFA: Translational Research
Year awarded: 2005
Preclinical Toxicology And Pharmacology Of MV-NIS, A Replicating Measles Virus For Myeloma Gene Therapy
Mayo Clinic
Fellows' Award
Investigator: David Dingli, MD
Year awarded: 2003
Prime-boost DNA/Adeno-associated Viral (AAV) Vaccine For Multiple Myeloma With MAGE A3-NY-ESO-1 Fusion Genes
University of Arkansas for Medical Science
Senior Research Award
Investigator: Ramesh B. Batchu, Ph.D.
Year awarded: 2004
Probing The Ubiquitin-Proteasome Pathway In Multiple Myeloma
Harvard Medical School
Senior Research Award
Investigator: Benedikt Kessler, PhD
Year awarded: 2002
Profiling IL-6 And Stromal Induced Gene Expression And Signal Transduction In Myeloma Cell Lines
University of Minnesota
Senior Research Award
Investigator: Brian Van Ness, PhD
Year awarded: 2000
Program Pathogenesis And Treatment Of Myeloma Bone Disease
Collaborative Program Grant
Amount: $1,500,000.00
Year awarded: 2003
Proteasome Inhibition And The Terminal Unfolded Protein Response
University of Miami Miller School of Medicine
Senior Research Award
Investigator: Lawrence H. Boise, PhD
Year awarded: 2005
Purified Blood DC Vaccination With Multiple Myeloma
Mater Medical Research Institute, Australia
Senior Research Award
Investigator: Derek Nigel John Hart, MB, ChB, DPhil
Year awarded: 2002
Pyk2 Phosphorylation By FGFR3 In Multiple Myeloma
University of California, San Diego
Senior Research Award
Investigator: Daniel J. Donoghue, PhD
Year awarded: 2002
Randomized Phase II Trial Of Dendritic Cell-Based Idiotype And Post-Transplant Multiple
Mayo Clinic
Fellows' Award
Investigator: Martha Lacy, MD
Year awarded: 2001
Recombinant Immunotoxins For Minor Histocompatibility Antigen Based Treatment Of Multiple Myeloma
Leiden University Medical Center
Senior Research Award
Investigator: Els Goulmy, PhD
Year awarded: 2005
Renoprotection In Multiple Myeloma By Pituitary Adenylate Cyclase Activating Polypeptide
Tulane University Health Sciences Center
Fellows' Award
Investigator: Min Li, MD, PhD
Year awarded: 2005
Role Of Bone Marrow Stromal Cells In De Novo Resistance Of Myeloma Cells To Chemotherapeutic Drugs
H. Lee Moffitt Cancer Center at the University of South Florida
Fellows' Award
Investigator: Yulia Nefedova, MD, PhD
Year awarded: 2002
Role Of GILZ In The Blucocorticoid Signaling Pathway Of Multiple Myeloma
Northwestern University
Senior Research Award
Investigator: Nancy Krett, PhD
Year awarded: 2003
Role Of MIP-1a In Myeloma Bone Disease
University of Texas Health Science Center of San Antonio
Senior Research Award
Investigator: G. David Roodman, MD, PhD
Year awarded: 2000
Role Of STAT3 In Multiple Myeloma
New York University School of Medicine
Fellows' Award
Investigator: Manual A. Macapinlac, Jr., MD
Year awarded: 2002
Role Of Differential CD8 T Cell Therapies For Mm
Harvard Medical School
Fellows' Award
Investigator: Irina B. Mazo, MD, PhD
Year awarded: 2004
Role Of The Non-hematopoietic Bone Marrow Stroma In Multiple Myeloma: In Vivo Studies With Primary Myeloma Cells In The SCID-hu Host
University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Shmuel Yaccoby, PhD
Year awarded:
Role Of The Alternative NF-_B Pathway In Multiple Myeloma
University of Pittsburgh
Senior Research Award
Investigator: Preet M. Chaudhary, MD, PhD
Year awarded: 2005
Screening A Chemical Library Tio Identify Novel Inhibitors Of C-maf-mediated Cyclin D2 Transactivation
Princess Margaret Hospital and Ontario Cancer Center
RFA: Compound Library Screening
Investigator: David Schimmer, MD, PhD
Year awarded: 2005
Screening For Inhibitors Of Transcription Factors Essential For The Survival Of Multiple Myeloma Cells: STAT3 And NF-kB
Dana Farber Cancer Institute
RFA: Compound Library Screening
Investigator: David Frank, MD, PhD
Year awarded: 2005
Selective Inhibition Of HDAC6 In The Treatment Of Multiple Myeloma
Broad Institute of Harvard and MIT
RFA: Therapeutic Targets Initiative
Investigator: James E. Bradner, MD
Year awarded: 2005
Stahmin: A Novel Target For Multiple Myeloma Therapy.
University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Jin Yi Wang, MD, PhD
Year awarded: 2000
Studies Of The CXCR4/P13Kinase Pathway In Multiple Myeloma
Mayo Clinic
Fellows' Award
Investigator: Irene M. Ghobrial, MD
Year awarded: 2004
Study Of The Existence Of Abnormal IgH Chromosomal Rearrangements And At The Occurence Of Isotype-Switch Variants In The 5T Myeloma Mouse Model.
Free University, Brussels
Fellows' Award
Investigator: Marleen Bakkus, MD, PhD
Year awarded: 2000
Targeted Therapy Of Multiple Myeloma By Splice-switching Of Anti-apoptotic MCL1 To Death Inducing Forms
Dartmouth Medical School
Senior Research Award
Investigator: Ruth W. Craig, PhD
Year awarded: 2005
Targeting CD28 For The Treatment Of Multiple Myeloma
University of Miami Miller School of Medicine
RFA: Translational Research
Investigator: Kelvin Lee, MD
Year awarded: 2005
Targeting CD40 Therapy Using Humanized MAbs, Alone Or With IMiD3 In Human MM
Dana Farber Cancer Institute
Senior Research Award
Investigator: Yu-Tzu Tai, Ph.D.
Year awarded: 2004
Targeting DKK1 In Multiple Myeloma With Humanized Anti-DKK1 Neutralizing Antibody
University of Arkansas for Medical Sciences
RFA: Translational Research
Investigator: Shmuel Yaccoby, PhD
Year awarded: 2005
Targeting ERAD And UPR In Multiple Myeloma
Center for Cancer Research, NCI-Frederick
RFA: Therapeutic Targets Initiative
Investigator: Allan M. Weissman, MD
Year awarded: 2005
Targeting Multiple Myeloma With R-Etodolac
University of California, San Diego
Senior Research Award
Investigator: Dennis Carson, MD
Year awarded: 2001
Targeting Telomere Expansion Mechanisms For Multple Myeloma
Harvard Medical School
Fellows' Award
Investigator: Masood Shammas, PhD
Year awarded: 2001
Targeting Chemoresistance In Multiple Myeloma Cells By Curcumin
University of Texas M.D. Anderson Cancer Center
Senior Research Award
Investigator: Bharat Aggarwal, PhD
Year awarded: 2003
Targeting Microenvironment Pro-survival Signals Through CD28
University of Miami
Senior Research Award
Investigator: Kelvin Lee, M.D.
Year awarded: 2004
Targeting Mitochondria To Overcome Conventional And Bortezomib/Proteasome Inhibitor PS-341 Resistance In Multiple Myeloma Cells
Dana Farber Cancer Institute
Senior Research Award
Investigator: Dharminder Chauhan, J.D., Ph.D.
Year awarded: 2004
Targeting Multiple Myeloma By HM 1.24 Specific Measles Virus Delivered By T-cells
Julius-Maximillian Universitat Wurzburg, Germany
Senior Research Award
Investigator: Max S. Topp, MD
Year awarded: 2005
Targeting Myeloma Progenitors: Evaluation By Minimal Residual Disease As Clinical End Point In Phase II Studies Of New Treatment Modalities In Patients With Multiple Myeloma
Herlev University Hospital
Senior Research Award
Investigator: Hans Johnsen, MD, DMSc
Year awarded: 2003
The 5TMM Murine Models Of Myeloma As Tools To Study The Biology Of Multiple Myeloma - Part 1: Setup Of A Core Facility For The Maintenance Of 5TMM Models And In Vivo Experimentation
Free University of Brussels
Senior Research Award
Investigator: Karin Vanderkerken, PhD
Year awarded: 2003
The 5TMM Murine Models Of Myeloma As Tools To Study The Biology Of Multiple Myeloma - Part 2: Studies Of Myeloma Bone Disease
University of Sheffield Medical School
Senior Research Award
Investigator: Peter Croucher, PhD
Year awarded: 2003
The AKT-mTOR Pathway In Multiple Myeloma
West Los Angeles VA Hospital of the Greater Los Angeles Healthcare System
Fellows' Award
Investigator: Yijiang Shi, PhD
Year awarded: 2002
The Control Of Proliferation, Survival And Apoptosis In Multiple Myeloma
Uppsala University, Sweden
Senior Research Award
Investigator: Helena Jemberg Wiklund, PhD
Year awarded: 2000
The IGF/IGF-1R System As A Major Therapeutic Target For Myeloma
Dana Farber Cancer Institute
Fall Senior Research Award
Investigator: Constantine S. Mitsiades, MD, PhD
Year awarded: 2002
The Molecular Chaperone Hsp90 As A Novel Therapeutic Target For Multiple Myeloma
Dana Farber Cancer Institute
Fellows' Award
Investigator: Constantine Mitsiades, MD, M.Med.Sc
Year awarded: 2001
The Role Of CDK2 In Fibronectin Induced Regulation Of P27 Levels
H. Lee Moffitt Cancer Center
Fellows' Award
Investigator: Lori A. Hazlehurst, PhD
Year awarded:
The Role Of Kaposi's Sarcoma-Associated Virus In Multiple Myeloma Pathogenesis: Oncogenic And Angiogenic Potential Of Orf72 And Orf74
Dana Farber Cancer Institute
Senior Research Award
Investigator: Noopur Raje, MD
Year awarded:
The Role Of Ku86v In The Pathogenesis Of Mutliple Myeloma.
Dana Farber Cancer Institute
Fellows' Award
Investigator: Yu-Tzu Tai, PhD
Year awarded: 2000
The Role Of MMSET In Multiple Myeloma
Weill Medical College of Cornell University
Senior Research Award
Investigator: Marta Chesi, PhD
Year awarded: 2002
The Role Of MVP/Vaults In The Generation Of Drug Resistance In Multiple Myeloma
University Hospital Rotterdam, The Netherlands
Senior Research Award
Investigator: Pieter Sonneveld, MD, PhD
Year awarded: 2001
The Role Of Macrophage Inflammatory Protein-1 Alpha In The Development Of Osteolytic Bone Lesions In Myeloma
Univ. of Texas Health Science Center at San Antonio
Fellows' Award
Investigator: Babatunde Oyajobi, PhD
Year awarded:
The Role Of Proline-Rich Tyrosine Kinase PYK2 In Dexamethasone-Induced Apoptosis In Multiple Myeloma Cells
Dana Farber Cancer Institute
Fellows' Award
Investigator: Dharminder Chauhan, PhD
Year awarded:
The Role Of RANK/RANK Ligand Interaction In The Development Of Multiple Myeloma Disease: Study In The 5TMM Model
Free University Brussels
Fellows' Award
Investigator: Karin Vanderkerken, PhD
Year awarded: 2001
The Significance Of DNA Repair In Mediating Resistance Associated With Adhesion Of Myeloma Cells To Fibronectin
H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Lori Hazlehurst, PhD
Year awarded: 2001
The Immunoproteasome As A Target For Multiple Myeloma Therapy
University of North Carolina at Chapel Hill
RFA: Therapeutic Targets Initiative
Investigator: Robert Z. Orlowski, MD, PhD
Year awarded: 2005
The Incidence Of Amyloid Deposition In Abdominal And Oral Mucosal Tissue In Patients Initially Diagnosed With Multiple Myeloma
University of Pennsylvania School of Dental Medicine
Fellows' Award
Investigator: Eric T. Stoopler, BA, DMD
Year awarded: 2005
Therapeutic Effect Of Idiotype-specific CD4+ T Cells Against Multiple Myeloma
University of Oslo / Institute of Immunology
Fellows' Award
Investigator: Alexandre Corthay, MSc, PhD
Year awarded: 2005
Therapeutic Targeting Of FGFR3 Pathways In Multiple Myeloma
University of California, Irvine
Senior Research Award
Investigator: Leslie Michels Thompson, PhD
Year awarded: 2005
Therapuetic Intervention In Myeloma: FGFR3 As Drug Target
Weill Medical College of Cornell University
Fellow's Award
Investigator: Suzanne Trudel, MD, MSc
Year awarded: 2002
The Role Of LIGHT/TNFSF14 And DcR3 In The Pathophysiology Of Multiple Myeloma
University of Oxford
Fellows' Award
Investigator: Claire Shipman, PhD
Year awarded: 2003
The Role Of C-maf In Multiple Myeloma
Toronto General Research Institute
Fellows' Award
Investigator: Yuan Xiao Zhu, MD
Year awarded: 2003
The Role Of Heat Shock Protein 70 (HSP70) On MM-stromal Cell Interactions
Moffitt Cancer Center
Fellows' Award
Investigator: Nimmanapalli Ramadevi, DPhil
Year awarded: 2003
The Role Of Lipid Rafts In Multiple Myeloma Pathogenesis
Dana Farber Cancer Institute
Senior Research Award
Investigator: Klaus Podar, MD, PhD
Year awarded: 2003
The Significance Of The Unfolded Protein Response Pathway In Multiple Myeloma And Its Potential As A Therapeutic Target
Toronto General Research Institute
Fellows' Award
Investigator: Esther Masih-Khan, PhD
Year awarded: 2003
Transcriptional Functions And Targets Of The MMSET Protein Of T(4:14) Myeloma
Mount Sinai School of Medicine
Senior Research Award
Investigator: Jonathan D. Licht, MD
Year awarded: 2005
Transgenic Mouse Model Of Multiple Myeloma
Weill Medical College of Cornell University
Senior Research Award
Investigator: P. Leif Bergsagel, MD
Year awarded:
Translational Network Validating The IGF-1R As A Therapeutic Target In Multiple Myeloma Models In Vitro And In Vivo
Uppsala University/Vrije Universiteit Brussel
RFA: Translational Research
Investigator: Helena Jernberg Wiklund, PhD, Karin Vanderkerke
Year awarded: 2005
Translational Control Of Apoptosis In Multiple Myeloma: Molecular Mechanisms Whereby MTOR Inhibitors Sensitize Cells To Apoptosis
West LA VA Medical Center
Fellow's Award
Investigator: Huajun Yan, PhD
Year awarded: 2004
Translational Studies Of IGFs/IGF-1R Inhibition For The Treatment Of MM
Dana-Farber Cancer Institute
Senior Research Award
Investigator: Constantine S. Mitsiades, M.D., Ph.D.
Year awarded: 2004
Treatment Of Multiple Myeloma By Antibody Mediated Immunotherapy And Induction Of Tumor Selective Antigens
Dana-Farber Cancer Institute
Fellow's Award
Investigator: Steven Peter Treon, MD
Year awarded:
Tumor Vaccines For Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation.
Johns Hopkins University School of Medicine
Senior Research Award
Investigator: Hyam I. Levitsky, MD
Year awarded:
Vaccination Against Multiple Myeloma With Vaccibodies From Experimental Immunology To Patients
University of Oslo, norway
Senior Research Award
Investigator: Bjarne Bogen, M.D., Ph.D.
Year awarded: 2004
Validation Of Melphalan-resistance Targets In Vitro In Human Mm Cell Lines Utilizing A Retroviral Based RNAi Delivery System
Van Andel Research institute
Fellow's Award
Investigator: Jennifer Lisa Bromberg-White, BA, PhD
Year awarded: 2004
Validation Of Potential Myeloma Target Antigens For Blood Dendritic Cell Immunotherapy
Mater medical research Institute
Senior Research Award
Investigator: Derek nigel John Hart, M.B, Ch.B, DPhil
Year awarded: 2004
Variants Of Ku86 Autoantigen Are Preferentially Expressed In Multiple Myeloma And Required For Malignant Transformation
Dana-Farber Cancer Institute
Fellow's Award
Investigator: Yu-Tzu Tai, PhD
Year awarded:
P62ZIP And Myeloma Bone Diseases
University of Pittsburgh
Fall Senior Research Award
Investigator: G. David Roodman, MD, PhD
Year awarded: 2002